Mesothelioma treatment falls into four main categories: surgery, chemotherapy, radiation therapy, and immunotherapy, according to the National Cancer Institute’s treatment summary (NCI PDQ). Most people receive a combination, chosen based on the stage, the cell type, where the cancer is, and the person’s overall health.
This page explains what each category is, with sources. It is informational only, not medical advice, and it recommends no hospital, doctor, or protocol. Treatment decisions belong with your care team, and for a rare cancer, the American Cancer Society notes that care often involves a team of doctors from different fields.
What surgery is used for mesothelioma?
Surgery for pleural mesothelioma aims either to remove as much cancer as possible or to relieve symptoms. The ACS surgery guide describes the major operations, including pleurectomy with decortication, which removes the pleura and visible tumor while sparing the lung, and extrapleural pneumonectomy, a larger operation that removes the lung on the affected side along with surrounding tissue. Whether surgery is an option depends heavily on stage and fitness; our stages page explains that connection. The same ACS guide also covers smaller procedures done to drain fluid and ease breathing rather than to remove cancer.
For peritoneal mesothelioma, the ACS describes surgery to remove tumor from the abdomen, often combined with heated chemotherapy delivered directly into the abdominal cavity during the operation, an approach covered on our peritoneal mesothelioma page.
How is chemotherapy used?
Chemotherapy uses drugs that kill fast-dividing cells, given by IV or, in the peritoneal form, sometimes directly into the abdomen. Per the NCI PDQ summary, chemotherapy may be used as the main treatment when surgery is not an option, or around surgery to attack remaining cancer cells. The ACS treatment section describes the drug combinations commonly used and their side effects; the specifics of any regimen, and whether it fits, are questions for the oncologist.
What is immunotherapy?
Immunotherapy drugs help the body’s own immune system recognize and attack cancer cells. The NCI’s PDQ summary lists immunotherapy among the treatments used for malignant mesothelioma, and the American Cancer Society covers the immune checkpoint inhibitor drugs used for pleural disease that cannot be removed surgically. This category is newer than the others, which matters when reading survival statistics built mostly from earlier years, a point explained on our prognosis page.
Where does radiation fit?
Radiation therapy uses focused high-energy beams to kill cancer cells in a targeted area. Per the NCI PDQ, radiation may be used after surgery, or to shrink tumors that are causing pain or pressure. It is a local treatment, so it is usually one piece of a larger plan rather than the whole plan.
How is a treatment plan chosen?
Per the National Cancer Institute’s PDQ summary, the plan depends on where the mesothelioma is, how far it has spread, the cell type identified in the biopsy, and the patient’s age and general health. That is why two people with the same diagnosis can be offered very different plans, and why a plan can change after surgery reveals more or less disease than the scans suggested.
Useful questions for the oncologist: what is this treatment meant to accomplish, control the cancer, shrink it, or ease symptoms; what side effects should we plan around; how will we know whether it is working; and is a clinical trial an option here. Because mesothelioma is rare, with about 3,000 new US cases a year per the American Cancer Society, families often seek a second opinion from a center that sees the disease regularly. That is a normal step, not a challenge to anyone’s judgment.
What about palliative care and clinical trials?
Two things families sometimes misunderstand. Palliative care is symptom care, aimed at breathing, pain, and quality of life, and it runs alongside active treatment, not instead of it; the ACS describes palliative procedures as a standard part of mesothelioma care at any stage. Clinical trials are studies of new treatments, and the NCI maintains listings of open mesothelioma trials. Whether a trial makes sense is a conversation for the care team, but it is always fair to ask whether one fits.
Be careful with anything marketed as a cure. No mainstream authority describes one, and a family in crisis is exactly who miracle claims are aimed at. If a claim about a treatment does not appear on NCI or ACS pages, treat it with caution and bring it to the oncologist before acting on it.
What this means for your family
Treatment is expensive, and the costs land while the family’s income is often falling. This is the practical purpose of an asbestos claim: compensation for medical costs, lost income, and the harm done. Roughly $30 billion sits in asbestos bankruptcy trust funds set aside for people injured by asbestos products, per the U.S. Government Accountability Office (GAO-11-819), separate from any lawsuit. Pennsylvania’s filing window is generally two years from diagnosis (42 Pa. C.S. § 5524), and a claim can move forward while treatment continues, without the patient carrying the load.
If treatment costs are already weighing on your family, request a free case review and find out what compensation paths are open to you.